Close Menu

More articles about Clinical Lab Management

OIG will evaluate data to assess whether PAMA pricing results in market-based rates

With only one test FDA-approved for primary hrHPV screening, groups express concern about feasibility of moving away from co-testing

The Garage's web-based platform is used exclusively by groups that employ value-based payment models

Smaller labs, hospital outreach labs, and labs servicing high numbers of elderly are thought to face the highest risks.

Quest is buying Shiel from Fresenius Medical Care, and it lowered its expected third quarter revenues by 1.5 percent and its EPS by $.10 on recent natural disasters.

Miraca provides subspecialty anatomic pathology services in gastroenterology, dermatology, hematology, breast health, and urology.

Project Santa Fe, formed last year by five health system-based labs, aims to share strategies and lab-driven programs for improving patient care with labs in other health systems.

The report builds on a study two years ago that found that at least 5 percent of Americans seeking outpatient care experience a diagnostic error. 

The company expects further growth in companion diagnostics and oncology from Covance and Chiltern acquisitions

Laboratories are developing mitigation strategies to raise awareness that biotin supplements may be interfering with some patient test results.

Yuzuki recently wrote a blog piece on reducing the costs associated with running a genomics lab and spoke with 360Dx on ways labs can manage cost waste.

The company estimates that the quality control issue resulted in between two and 15 patients getting a false negative result. 

Entering a new chapter with a new leader, ACLA lends support to a draft bill that would regulate lab tests not as medical devices but as in vitro clinical tests.

The AACC called for increased collaboration between physicians and laboratory medicine professionals, as Medicare changes how it reimburses for clinical lab tests.

With PAMA scheduled to be implemented in January, many believe M&A in the clinical lab space will heat up, with Quest and LabCorp the main beneficiaries. 

The agency said it is giving labs 60 additional days to report private payor rates but is still expecting to launch the new clinical lab fee schedule in 2018.

ACLA said the goal of the delay is to redefine "applicable laboratories" and give labs and CMS more time to collect data that will inform market-based pricing.

Mertz outlined the lab industry group's policy positions after FDA's decision to delay final guidance on regulation of lab tests and upcoming implementation of a payment law.

CMS gave labs an additional year to gear up for the implementation of the Protecting Access to Medicare Act of 2014 and clarified key programmatic definitions.